U.S. Department of Health & Human Services
National Institutes of Health
NCATS
This repository is under review for potential modification in compliance with Administration directives.
Dismiss
Return Home
Inxight
Drugs
Search Substances
Home
Browse Drugs
US Approved Drugs
Marketed Drugs
Investigational Drugs
All Substances
Search
Structure Search
Sequence Search
Downloads
About
Search Substances
OBEXELIMAB
RM16A4BA8R
Investigational
General
Names
9
Classification
1
Identifiers
8
Subunits
4
Related Substances
1
OBEXELIMAB
RM16A4BA8R
Investigational
General
Approval Year
Unknown
149,124
Names
9
Show
5
20
100
All
entries
Name
Type
Language
Name
Type
Language
OBEXELIMAB
Official Name
English
XMAB-5871
Preferred Name
English
XMAB5871 (HUMANIZED ANTI-CD19 ANTIBODY WITH AN FC PORTION ENGINEERED FOR INCREASED AFFINITY (200- TO 400-FOLD OVER NATIVE IGG) TO FCGRIIB)
Common Name
English
OBEXELIMAB [USAN]
Common Name
English
Obexelimab [WHO-DD]
Common Name
English
Showing 1 to 5 of 9 entries
Previous
1
2
Next
Classification
1
Show
5
20
100
All
entries
Classification Tree
Code System
Code
Classification Tree
Code System
Code
Designated
ORPHAN DRUG
Designated
Treatment of immunoglobulin G4-related disease
FDA ORPHAN DRUG
566516
Showing 1 to 1 of 1 entries
Previous
1
Next
Identifiers
8
Show
5
20
100
All
entries
Code System
Code
Type
Description
Code System
Code
Type
Description
USAN
FG-171
PRIMARY
DRUG BANK
DB15032
PRIMARY
SMS_ID
100000183087
PRIMARY
INN
10898
PRIMARY
FDA UNII
RM16A4BA8R
PRIMARY
Showing 1 to 5 of 8 entries
Previous
1
2
Next
Subunits
4
Subunit 0
>SUBUNIT_0
Subunit 1
>SUBUNIT_1
Subunit 2
>SUBUNIT_2
Subunit 3
>SUBUNIT_3
Related Substances
1
ACTIVE MOIETY
RM16A4BA8R
OBEXELIMAB